CAGE-AID helps flag alcohol and drug concerns that need follow-up
CAGE-AID is a brief screening questionnaire used to identify possible concerns related to alcohol or drug use. It is not a diagnostic interview. It does not establish a substance use disorder by itself. For therapists, counselors, social workers, psychologists, psychiatrists, and other behavioral health professionals, its main value is that it gives a quick, structured way to ask about substance-related concerns during intake, assessment, or treatment review.
The tool adapts the original CAGE alcohol screening questions to include drugs. The “AID” portion stands for “Adapted to Include Drugs,” which makes the questions relevant to both alcohol use and nonmedical drug use [source:2]. Research on the CAGE-AID has examined its criterion validity in primary care settings, supporting its use as a brief screening instrument rather than a stand-alone diagnostic measure [source:1].
Good documentation matters because CAGE-AID results often influence the next clinical step. A positive screen may lead the clinician to ask more detailed substance use questions, complete a fuller assessment, discuss safety concerns, provide brief intervention, coordinate care, or consider referral. The note should show what was asked, how the client responded, and what the clinician did with that information.
What the CAGE-AID measures
CAGE-AID screens for indicators that a person may be experiencing problems related to alcohol or drug use. The questions focus on four clinical themes: perceived need to cut down, criticism from others, guilt about use, and morning use to steady nerves or manage aftereffects.
- Cut down: Whether the client has felt they should reduce alcohol or drug use.
- Annoyed: Whether criticism from others has bothered the client.
- Guilty: Whether the client has felt bad or guilty about use.
- Eye-opener: Whether the client has used alcohol or drugs first thing in the morning to steady nerves, reduce discomfort, or manage a hangover.
Each item is typically answered “yes” or “no.” The University of Washington National HIV Curriculum describes CAGE-AID as a four-question screening tool adapted from CAGE to include both alcohol and drugs [source:2]. Because it is brief, it can be used early in the clinical conversation without replacing a full biopsychosocial assessment, substance use history, risk assessment, or DSM-based diagnostic evaluation.
The distinction between screening and assessment should remain clear in the record. Screening identifies possible risk. Assessment gathers more detailed information about pattern, frequency, consequences, impairment, readiness to change, safety, co-occurring symptoms, and treatment needs. SAMHSA describes Screening, Brief Intervention, and Referral to Treatment, often called SBIRT, as an approach for identifying and addressing substance use concerns through screening, brief intervention, and referral when indicated [source:3].
When clinicians commonly use CAGE-AID
CAGE-AID is often used when a clinician needs a brief substance use screen that fits into a broader behavioral health workflow. It may be part of an intake packet, an initial diagnostic assessment, a treatment plan update, or a reassessment after a clinical change.
Common use cases include:
- New client intake: Screening for alcohol and drug concerns as part of a biopsychosocial assessment.
- Annual or periodic review: Updating risk and substance use information during ongoing care.
- Clinical change: Re-screening after relapse, hospitalization, legal stressors, medication changes, or changes in mood, sleep, work, or relationships.
- Integrated care settings: Supporting brief identification of substance use concerns alongside mental health, medical, or case management services.
National recommendations also support substance use screening in appropriate clinical contexts. The U.S. Preventive Services Task Force recommends screening adults for unhealthy drug use when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred [source:4]. The USPSTF also recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in risky or hazardous drinking [source:5].
For behavioral health clinicians, CAGE-AID can be especially useful when the presenting concern is not substance use but substance-related patterns may affect treatment. Examples include anxiety with increased alcohol use at night, depression with nonmedical sedative use, trauma symptoms with cannabis use before sleep, or relationship conflict connected to drinking.
How CAGE-AID results should inform documentation
A CAGE-AID result should help the clinician decide what to document next. The note should not simply say “CAGE-AID positive” without context. A stronger note captures the client’s responses, the clinical meaning of those responses, and the plan for follow-up.
Useful documentation may include:
- The date of screening and clinical context, such as intake, reassessment, or treatment plan review.
- The client’s item-level responses or total score, depending on your setting’s policy.
- Relevant client statements, especially if they clarify frequency, consequences, or motivation.
- The follow-up plan, such as further assessment, brief intervention, monitoring, safety planning, or referral discussion.
Be careful with diagnostic language. A positive screen may support further evaluation, but it does not automatically mean the client meets criteria for a substance use disorder. DSM-5 substance use disorder criteria involve a broader pattern of symptoms, impairment, and clinical significance, not a four-item screen alone [source:7].
For example, “CAGE-AID score 2; client has alcohol use disorder” overstates what the tool can show. A more accurate statement would be: “CAGE-AID completed during intake. Client endorsed feeling they should cut down on alcohol use and feeling guilty about drinking. Results suggest need for further assessment of alcohol use pattern, consequences, and readiness to change.”
Documentation example for a CAGE-AID screen
The following example shows how a clinician might document CAGE-AID-related information without overstating conclusions. Adapt the wording to your scope, setting, payer requirements, and clinical record format.
Assessment documentation example:
“CAGE-AID administered as part of initial biopsychosocial assessment. Client answered ‘yes’ to Cut down and Guilty items and ‘no’ to Annoyed and Eye-opener items. Client reported drinking 3–4 nights per week, typically 2–4 drinks, with increased use during recent work stress. Client denied morning alcohol use, denied current illicit drug use, and denied withdrawal symptoms. Clinician provided brief feedback, explored connection between alcohol use, sleep disruption, and anxiety symptoms, and discussed options for tracking use over the next two weeks. Plan: continue assessment of alcohol use pattern, monitor risk, and revisit coping alternatives during next session.”
This example includes the screening context, item responses, relevant clinical detail, intervention, client-specific plan, and appropriate limits. It does not diagnose based only on the screen. It also avoids vague language such as “substance abuse suspected” without supporting details.
Common documentation mistakes with CAGE-AID
CAGE-AID is short, which can make it easy to document too little or to write conclusions that go beyond the available information. The most common problems are not usually about the tool itself. They are about how the result is carried into the clinical note.
Documenting only the score
A score alone may not explain the clinical picture. If the client endorses guilt but denies consequences, withdrawal, increased tolerance, or impairment, that context matters. If the client endorses morning use, the follow-up may need to be more specific. Record enough detail to support your next step.
Treating a screen as a diagnosis
A screening result can indicate that more assessment is needed. It should not be documented as proof of a diagnosis unless the clinician has completed an appropriate diagnostic evaluation and the documented findings support the diagnosis. Screening and assessment serve different functions in care planning [source:6].
Leaving out the client’s own words
Client statements can clarify meaning. “I only drink on weekends, but I feel guilty because my partner is worried” communicates something different from “I drink every morning to stop shaking.” Brief quotes can strengthen the note when they are clinically relevant.
Failing to connect results to the plan
If the screen suggests possible concern, the documentation should show what happened next. That may be further assessment, psychoeducation, motivational interviewing, referral discussion, harm-reduction planning, coordination with a prescriber, or continued monitoring.
How to document negative or declined CAGE-AID screens
Negative screens still need clear documentation. A brief statement may be enough when no concerns are identified, but it should include the context and any relevant clinical observations.
Negative screen example:
“CAGE-AID completed during intake. Client denied all four items. Client reported occasional alcohol use, approximately 1–2 drinks per month, and denied drug use. No current substance-related treatment needs identified based on screening and client report. Continue routine monitoring as clinically indicated.”
Some clients decline to answer substance use questions. That can be documented neutrally without implying noncompliance or dishonesty.
Declined screen example:
“CAGE-AID offered during intake. Client declined to answer substance use screening questions today, stating they were not ready to discuss this area. Clinician explained purpose of routine screening and offered to revisit at a later session. No acute substance-related safety concerns reported during today’s visit.”
This type of language respects client autonomy while showing that the clinician addressed the topic and made a plan to return to it when appropriate.
Where CAGE-AID fits in SOAP, DAP, and intake notes
CAGE-AID information can fit into different note formats. The best placement depends on your documentation workflow and the purpose of the session.
In a SOAP note, item responses and client report may appear in the Subjective section, observed presentation in Objective, clinical meaning in Assessment, and next steps in Plan. For example, the Assessment section might state that endorsed items indicate need for further substance use assessment, not that the screen confirms a disorder.
In a DAP note, the Data section may include responses and client statements. The Assessment section may describe clinical impressions, risk considerations, or relationship to treatment goals. The Plan section should identify follow-up actions.
During an intake assessment, CAGE-AID results often belong in the substance use history or screening measures section. If the screen affects diagnosis, treatment planning, risk, or referrals, it should also be reflected in the clinical formulation and plan.
How AutoNotes supports assessment-related documentation
AutoNotes helps clinicians create structured, editable progress note drafts from clinical details they provide. For CAGE-AID-related documentation, that means a clinician can include the screening context, client responses, relevant substance use history, interventions, and follow-up plan, then use AutoNotes to organize those details into a clearer draft.
AutoNotes does not need to replace the clinician’s assessment process. The clinician remains responsible for administering any screening tool, confirming responses, applying clinical judgment, reviewing the draft, editing the language, and finalizing the record.
For example, after an intake session, a therapist might enter session details such as: “CAGE-AID completed; yes to Cut down and Guilty; client reports drinking most evenings after work; denies morning use; discussed sleep and anxiety connection; plan to track use and revisit next session.” AutoNotes can help turn those details into a structured draft with sections for assessment data, clinical impressions, interventions, client response, and plan.
This can reduce after-hours writing time and improve consistency across notes. It can also help clinicians avoid common gaps, such as leaving out client response, failing to connect the screen to treatment goals, or documenting a score without a follow-up plan.
If your practice uses templates for intake, progress notes, treatment planning, or reassessment, AutoNotes can support a more organized documentation process while keeping the provider in control. You review. You edit. You decide what belongs in the final clinical record.
Start your free trial to see how AutoNotes can help you draft structured behavioral health notes faster.
Practical CAGE-AID documentation checklist
Use this checklist after a CAGE-AID screen to make sure the note supports clinical continuity without overstating the result.
- Did you document why the screen was completed, such as intake, reassessment, or clinical change?
- Did you record item responses, total score, or both, based on your setting’s workflow?
- Did you include relevant client statements about frequency, pattern, consequences, or readiness to change?
- Did you connect the result to a specific next step?
The strongest notes are usually brief but specific. They show the screening result, the clinical context, and the plan. They avoid unsupported diagnostic conclusions and leave a clear path for future sessions.
References
- [source:1] Conjoint Screening Questionnaires for Alcohol and Other Drug Abuse: Criterion Validity in a Primary Care Practice – PubMed
- [source:2] CAGE-AID Questionnaire – University of Washington National HIV Curriculum
- [source:3] Screening, Brief Intervention, and Referral to Treatment (SBIRT) – SAMHSA
- [source:4] Unhealthy Drug Use: Screening – U.S. Preventive Services Task Force
- [source:5] Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions – U.S. Preventive Services Task Force
- [source:6] Screening and Assessment – NCBI Bookshelf
- [source:7] DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale – National Center for Biotechnology Information